SELLAS Life Sciences Group, Inc. Acquisitions, Net of Cash Acquired
SELLAS Life Sciences Group, Inc. (SLS) reported Acquisitions, Net of Cash Acquired of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-05.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2016-04-15
- SELLAS Life Sciences Group, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
- SELLAS Life Sciences Group, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- SELLAS Life Sciences Group, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2013-12-31 was $5.07M.
- SELLAS Life Sciences Group, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2013-09-30 was $10.00M.
- SELLAS Life Sciences Group, Inc. payments to acquire businesses, net of cash acquired for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- SELLAS Life Sciences Group, Inc. payments to acquire businesses, net of cash acquired for fiscal 2013 was $15.14M.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 1 month | Payments to Acquire Businesses, Net of Cash Acquired 1 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month | Payments to Acquire Businesses, Net of Cash Acquired 123 month | Payments to Acquire Businesses, Net of Cash Acquired 126 month |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-03-05 | |||||||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $0.00 10-Q · filed 2014-08-11 | $5.07M derived: sum of 3 quarters · filed 2015-03-05 | $15.07M derived: sum of 4 quarters · filed 2015-03-05 | ||||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-06 | $5.07M derived: sum of 2 quarters · filed 2015-03-05 | $15.07M derived: sum of 3 quarters · filed 2015-03-05 | $25.07M derived: sum of 4 quarters · filed 2015-03-05 | ||||
| 2013-12-31 | $5.07M derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-03-05 | $15.07M derived: sum of 2 quarters · filed 2015-03-05 | $25.07M derived: sum of 3 quarters · filed 2015-03-05 | $15.14M 10-K · filed 2015-03-05 | ||||
| 2013-10-31 | $10.00M 10-Q · filed 2015-08-06 | $10.09M 10-Q · filed 2014-05-06 | ||||||
| 2013-09-30 | $10.00M 10-Q/A · filed 2013-11-07 | $20.00M derived: sum of 2 quarters · filed 2013-11-07 | $10.07M 10-Q/A · filed 2013-11-07 | |||||
| 2013-06-30 | $10.00M 10-Q · filed 2013-08-09 | $10.08M 10-Q · filed 2014-08-11 | $10.08M 10-Q · filed 2013-08-09 | |||||
| 2013-03-31 | $10.09M 10-Q · filed 2014-05-06 | $10.09M 10-Q/A · filed 2013-11-07 | ||||||
| 2013-03-30 | $10.00M 10-K/A · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |